{
    "eid": "2-s2.0-85058819617",
    "title": "Real-life clinical pattern, management, and survival in Thai patients with early-stage or metastatic triple-negative breast cancer",
    "cover-date": "2018-12-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Multidisciplinary",
            "@code": "1000",
            "@abbrev": "MULT"
        }
    ],
    "keywords": [],
    "authors": [
        "Vichien Srimuninnimit",
        "Piti Pornpraserthsuk",
        "Arkom Chaiwerawattana",
        "Youwanush Kongdan",
        "Teerayuth Namkanisorn",
        "Areewan Somwangprasert",
        "Chulaporn Jatuparisuthi",
        "Puttisak Puttawibul",
        "Mawin Vongsaisuwan",
        "Luangyot Thongthieang",
        "Chanyoot Bandidwattanawong",
        "Chaturong Tantimongkolsuk"
    ],
    "citedby-count": 5,
    "ref-count": 30,
    "ref-list": [
        "Metastatic triple negative breast cancer: Optimizing treatment options, new and emerging therapies",
        "Current approaches in treatment of triple-negative breast cancer",
        "Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer",
        "Triple-negative breast cancer: An unmet medical need",
        "New therapeutic strategies for triple-negative breast cancer",
        "Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors",
        "Asian ethnicity and breast cancer subtypes: A study from the California Cancer Registry",
        "Survival time and molecular subtypes of breast cancer after radiotherapy in Thailand",
        "Incidence and mortality of female breast cancer in the Asia-Pacific region",
        "National and subnational population-based incidence of cancer in Thailand: Assessing cancers with the highest burdens",
        "Triple negative breast cancer in Asia: An insider\u2019s view",
        "Triple-negative breast cancer",
        "Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials",
        "Selection of optimal adjuvant chemotherapy regimens for early breast cancer and adjuvant targeted therapy for human epidermal growth factor receptor 2-positive breast cancers: An American society of clinical oncology guideline adaptation of the cancer Care Ontario clinical practice guideline",
        "De-escalating and escalating treatments for early-stage breast cancer: The St. Gallen international expert consensus conference on the primary therapy of early breast cancer 2017",
        "A review of systemic treatment in metastatic triple-negative breast cancer",
        "Practical approach to triple-negative breast cancer",
        "Classical cyclophosphamide, methotrexate, and fluorouracil chemotherapy is more effective in triple-negative, node-negative breast cancer: Results from two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer",
        "Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer",
        "Adjuvant treatments for triple-negative breast cancers",
        "Responsiveness of intrinsic subtypes to adjuvant anthracycline substitution in the NCIC.CTG MA.5 randomized trial",
        "Benefit from anthracyclines in relation to biological profiles in early breast cancer",
        "Descriptive analysis of estrogen receptor (ER)negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: A population-based study from the California Cancer Registry",
        "Analysis of pattern, time and risk factors influencing recurrence in triple-negative breast cancer patients",
        "Survival outcomes for patients with metastatic triple-negative breast cancer: Implications for clinical practice and trial design",
        "Triple-negative breast cancer: Clinical features and patterns of recurrence",
        "HER2 and response to paclitaxel in node-positive breast cancer",
        "Docetaxel-containing adjuvant chemotherapy in patients with early stage breast cancer. Consistency of effect independent of nodal and biomarker status: A meta-analysis of 14 randomized clinical trials",
        "Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): An open-label, phase III, randomised controlled trial",
        "Role of taxanes in triple-negative breast cancer: A study from tertiary cancer center in South India"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60199578",
            "affilname": "Ramathibodi Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199575",
            "affilname": "Siriraj Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199571",
            "affilname": "Bangkok Metropolitan Administration General Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199571",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": null,
            "@id": "60029487",
            "affilname": "National Cancer Institute Thailand",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60029487",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Hatyai",
            "@id": "60028394",
            "affilname": "Songklanagarind Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028394",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028340",
            "affilname": "Prapokklao Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028340",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60020352",
            "affilname": "Vajira Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020352",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Chaing Mai",
            "@id": "60013855",
            "affilname": "Maharaj Nakorn Chiang Mai Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60013855",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Khon Kaen",
            "@id": "60012921",
            "affilname": "Khon Kaen Regional Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012921",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "114718965",
            "affilname": "Somdech Phra Pinklao Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/114718965",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Lopburi",
            "@id": "101521982",
            "affilname": "Lopburi Cancer Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/101521982",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Sanofi"
    ]
}